PTX : Summary for Pernix Therapeutics Holdings, I - Yahoo Finance

U.S. Markets closed

Pernix Therapeutics Holdings, Inc. (PTX)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.61-0.07 (-2.61%)
At close: 4:00PM EST
People also watch
EBIOXGTIGEVOSKLNSPHS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.68
Open2.69
Bid2.51 x 600
Ask3.30 x 100
Day's Range2.56 - 2.70
52 Week Range0.39 - 4.80
Volume141,576
Avg. Volume397,298
Market Cap24.79M
Beta2.23
PE Ratio (TTM)-0.11
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire16 days ago

    Pernix Therapeutics Provides Update on Arbitration

    MORRISTOWN, N.J., Feb. 03, 2017-- Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company with a focus on Pain and CNS conditions, today provided an update on the Company’ s arbitration ...

  • Capital Cubelast month

    ETFs with exposure to Pernix Therapeutics Holdings, Inc. : January 20, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Pernix Therapeutics Holdings, Inc. Here are 5 ETFs with the largest exposure to PTX-US. Comparing the performance and risk of Pernix Therapeutics Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • GlobeNewswirelast month

    Pernix Therapeutics Appoints Ken Piña as General Counsel and Chief Compliance Officer

    MORRISTOWN, N.J., Jan. 06, 2017-- Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company with a focus on pain and CNS conditions, today announced the appointment of Ken Piña as Senior Vice ...